Health & Veritas Joshua Sharfstein: Policy and Health
Jul 18, 2024
Joshua Sharfstein, a seasoned public health leader and director of the Bloomberg American Health Initiative, shares insights on pressing health issues. He discusses the ongoing opioid crisis, highlighting the risks of fentanyl and the need for accessible treatment options. Sharfstein also reflects on the lessons learned from COVID-19 vaccine distribution and the importance of building trust in health messaging. Additionally, he addresses the preparedness for potential bird flu outbreaks and advocates for clear policy standards in AI-assisted medical diagnosis.
AI Snips
Chapters
Books
Transcript
Episode notes
Fentanyl Drives The Deadliest Wave
- The overdose crisis has worsened in waves and is now driven by a dangerously potent fentanyl supply.
- Methadone and buprenorphine rapidly protect receptors and dramatically increase treatment engagement when started quickly, Joshua Sharfstein explains.
Start Medications Immediately After Overdose
- Give people medication-assisted treatment immediately, especially in emergency settings, to prevent withdrawal and increase follow-up.
- Start methadone or buprenorphine in the ER to multiply chances of staying in treatment, Joshua Sharfstein advises.
Balance Strong Guidance With Clear Explanation
- Vaccine policy sits between voluntary recommendation and broad mandates and must be clearly justified.
- Transparent, sustained explanation from agencies could have reduced misinformation and improved public trust, Joshua Sharfstein observes.
